FDA Peptide Tracker

Liraglutide: live FDA regulatory status

GLP-1 weight-loss · GLP-1

The two signals

Plain-English verdict: green.

Regulatory status: 503A shortage exception · 503B shortage pathway retained (drug in shortage).

These two never collapse into one. Removal from a list is not the same as legal-to-compound, and neither is the same as available.

Availability at Peptós.LIFE

Available

What happens next

503B comments close — Jun 29, 2026

Regulatory timeline

Liraglutide: common questions

Is compounded Liraglutide legal in 2026?
It is available today through the 503A shortage-exception pathway, on a valid prescription from a licensed clinician. That pathway is narrowing: the FDA has proposed permanently excluding GLP-1 bulks from 503B, and comments closed June 29, 2026. Compounded medications are prepared for an individual patient and are not FDA-approved.
Can I get Liraglutide right now?
Yes, if a US-licensed clinician reviews your information and decides it is appropriate. We make no promise about how long supply lasts — the regulatory pathway is actively winding down, and we would rather say that than imply it is permanent.
Is compounded Liraglutide the same as the brand drug?
No. Compounded Liraglutide is prepared for an individual patient and is not FDA-approved. The FDA-approved brand products have been reviewed for safety and efficacy; a compounded preparation has not.
What happens next for Liraglutide?
The 503B exclusion comment period closed June 29, 2026. The FDA's next move on that proposal is the milestone to watch, and it could change availability.

PCAC is advisory: its Jul 2026 recommendation leads to rulemaking, not instant availability. A favorable advisory vote is a recommendation, not FDA approval or authorization to compound. Realistic earliest legitimate access is late 2026 into 2027. Reclassification is not the same as FDA approval. Compounded medications are not evaluated or approved by the FDA for safety, efficacy, or quality, where that applies, we say so, plainly.

Primary source: FDA source record

See the full status board.

Embed this card on your site · free, CC BY 4.0, no key.

Last updated July 26, 2026 · Peptós.LIFE · Not medical advice.